US Patent Issued to Hoffmann-La Roche on Dec. 16 for "Oligonucleotides for modulating RTEL1 expression" (Swiss, Danish, French, German Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,621, issued on Dec. 16, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).

"Oligonucleotides for modulating RTEL1 expression" was invented by Marco Berrera (Flueh, Switzerland), Josephine Felber (Basel, Switzerland), Jean-Christophe Hoflack (Saint-Louis, France), Susanne Kammler (Holte, Denmark), Tony Kam-Thong (Basel, Switzerland), Brian Leonard (Riehen, Switzerland), Lykke Pedersen (Copenhagen NV, Denmark), Philipp Tropberger (Loerrach, Germany), Miriam Triyatni (Basel, Switzerland), Daniel Jeremy Turley (Basel, Switzerland), Angelina Wallier (Flueh, Switzerland) and Jitao David Zhang (Riehen, Switzerland).

According to the abstract* released by the U.S. Patent & Trad...